欢迎光临源叶生物,登录 | 注册 |
当前位置: 首页 > 小分子化合物 > 小分子抑制剂 > BMS-777607

商品分类

浏览历史

S80030

BMS-777607

MedMol 98%
  • 英文名:
  • BMS-777607
  • 别名:
  • N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide
  • CAS号:
  • 1025720-94-8
  • 分子式:
  • C25H19ClF2N4O4
  • 分子量:
  • 512.89
  • 核磁/质谱:
品牌货号产品规格市场价(RMB)您的折扣价(RMB)库存(上海) 北京 武汉 南京 数量计量单位 加入购物车...
MedMol S80030-1mg 98% ¥320.00元 ¥217.60元 10 0 0 0 EA 加入购物车
MedMol S80030-2mg 98% ¥420.00元 ¥285.60元 10 0 0 0 EA 加入购物车
MedMol S80030-5mg 98% ¥750.00元 ¥510.00元 7 0 0 0 EA 加入购物车
MedMol S80030-10mg 98% ¥1200.00元 ¥816.00元 6 0 0 0 EA 加入购物车
MedMol S80030-25mg 98% ¥2600.00元 ¥1768.00元 5 0 0 0 EA 加入购物车
MedMol S80030-50mg 98% ¥3800.00元 ¥2584.00元 预计交期:2-3天 0 0 0 EA 加入购物车
MedMol S80030-100mg 98% ¥6900.00元 ¥4692.00元 预计交期:2-3天 0 0 0 EA 加入购物车
大包装询价

提交您的电话号码并同意《个人信息授权与保护申明》,到货后将短信提示。
提交

产品介绍

参考文献

质检证书(COA)

摩尔浓度计算器

相关产品

  • 提示:详情请下载说明书。
  • 产品描述: BMS 777607 (BMS 817378) is a Met-related inhibitor for c-Met, Axl, Ron and Tyro3 with IC50s of 3.9 nM, 1.1 nM, 1.8 nM and 4.3 nM, respectively, and 40-fold more selective for Met-related targets than Lck, VEGFR-2, and TrkA/B, with more than 500-fold greater selectivity versus all other receptor and non receptor kinases
  • 靶点: IC50: 3.9 nM (c-Met), 1.1 nM (Axl), 1.8 nM (Ron), 4.3 nM (Tyro3)
  • 体内研究: Oral administration of BMS 777607 (6.25-50 mg/kg) significantly reduces tumor volumes of the GTL-16 human tumor xenografts in athymic mice with no observed toxicity. Administration of BMS 777607 (25 mg/kg/day) decreases the number of KHT lung tumor nodules (28.3%), improves the morphological hemorrhage, and significantly impairs the metastatic phenotype in the 6-8 week-old female C3H/HeJ mice injected with rodent fibrosarcoma KHT cells without apparent systemic toxicity compared to the control treatment. A low dose of BMS 777607 (10 mg/kg) also offers a mild but not significant inhibition of lung nodule formation compared to the vehicle control.
  • 参考文献:
    1. Schroeder GM, et al. Discovery of N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (BMS-777607), a selective and orally efficacious inhibitor of the Met kinase superfamily. J Med Ch 2. Dai Y, et al. BMS-777607, a small-molecule met kinase inhibitor, suppresses hepatocyte growth factor-stimulated prostate cancer metastatic phenotype in vitro. Mol Cancer Ther, 2010, 9(6), 1554-1561. 3. Dai Y, et al. Impact of the small molecule Met inhibitor BMS-777607 on the metastatic process in a rodent tumor model with constitutive c-Met activation. Clin Exp Metastasis, 2012, 29, 253-261.
  • 溶解性: DMSO  :  ≥  39  mg/mL  (76.04  mM)
  • 保存条件: -20℃
  • 配置溶液浓度参考:
    1mg 5mg 10mg
    1 mM 1.95 ml 9.749 ml 19.497 ml
    5 mM 0.39 ml 1.95 ml 3.899 ml
    10 mM 0.195 ml 0.975 ml 1.95 ml
    50 mM 0.039 ml 0.195 ml 0.39 ml
  • 注意:部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。
输入产品批号:

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:


质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子量 (g/mol)


  • =
    *
    *


源叶所有产品仅用作科学研究,销售产品行为均适用于我司网上所列通用销售条款。